Sign In
Section Navigation
Common TitleAPV109141
Official Title Study of Once-Daily Versus Twice-Daily Fosamprenavir Plus Ritonavir, Administered With Abacavir/Lamivudine Once-Daily in Antiretroviral-Naive HIV-1 Infected Adult Subjects.
Phase Phase III
ClinicalTrials.gov NCT00450580
Categories Treatment-Naive
Funding
IndustryViiV Healthcare
References
  • Carosi G, Lazzarin , Stellbrink H, et al. Study of once-daily versus twice-daily fosamprenavir plus ritonavir administered with abacavir/lamivudine once daily in antiretroviral-naïve HIV-1-infected adult subjects. HIV Clin Trials. 2009;10:356-67.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.